Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating antibiotic prophylaxis during HDR brachytherapy for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CR-CSSS Champlain-Charles-Le Moyne | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED